The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world immune-related adverse events in patients with early triple negative breast cancer who received pembrolizumab.
 
Athira Jayan
No Relationships to Disclose
 
Jasmine S Sukumar
Honoraria - Sanofi (I)
 
Benjamin David Fangman
No Relationships to Disclose
 
Tejal Amar Patel
No Relationships to Disclose
 
Akshara Singareeka Raghavendra
No Relationships to Disclose
 
Diane D. Liu
No Relationships to Disclose
 
Ronald Rauch
No Relationships to Disclose
 
Karen Basen-Engquist
No Relationships to Disclose
 
Debashish Tripathy
Consulting or Advisory Role - Ambrx; AstraZeneca; Genomic Health; Gilead Sciences; GlaxoSmithKline; Menarini; Novartis; OncoPep; Personalis; Pfizer; Roche; Sermonix Pharmaceuticals
Research Funding - Ambrx (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Carlos Hernando Barcenas
Research Funding - Puma Biotechnology (Inst)